Comparative Effectiveness of Clopidogrel vs. Potent P2Y12 Inhibitors in CYP2C19 Normal Metabolizers Following Percutaneous Coronary Intervention: A Real-World Cohort Study.
Sign Up to like & getrecommendations! Published in 2025 at "British journal of clinical pharmacology"
DOI: 10.1002/bcp.70373
Abstract: BACKGROUND Evidence suggests that cytochrome P450 2C19 (CYP2C19) genotyping may guide clopidogrel therapy after percutaneous coronary intervention (PCI). However, evidence on the effectiveness of clopidogrel and potent P2Y12 inhibitors (ticagrelor or prasugrel) in patients with… read more here.
Keywords: percutaneous coronary; coronary intervention; effectiveness clopidogrel; potent ... See more keywords